Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease

Abstract Evidence from dopaminergic image and cerebral blood flow/metabolism images have shed light on symptomatology of cognitive aspects in brain physiology of healthy human as well as patients with Parkinson's disease. Cognitive impairment in Parkinson's disease is characterized by exec...

Full description

Saved in:
Bibliographic Details
Main Author: Shigeki Hirano (Author)
Format: Book
Published: BMC, 2021-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_a1c557d4c96e4d5dba1b2811598c3876
042 |a dc 
100 1 0 |a Shigeki Hirano  |e author 
245 0 0 |a Clinical implications for dopaminergic and functional neuroimage research in cognitive symptoms of Parkinson's disease 
260 |b BMC,   |c 2021-04-01T00:00:00Z. 
500 |a 10.1186/s10020-021-00301-7 
500 |a 1076-1551 
500 |a 1528-3658 
520 |a Abstract Evidence from dopaminergic image and cerebral blood flow/metabolism images have shed light on symptomatology of cognitive aspects in brain physiology of healthy human as well as patients with Parkinson's disease. Cognitive impairment in Parkinson's disease is characterized by executive, visuospatial, attentional disturbances. Dopaminergic system includes triadic parallel pathways. The mesostriatal pathway consist of posterolateral putamen and motor areas, the mesocortical pathway of dorsal caudate nucleus and dorsolateral prefrontal cortex, and the mesolimbic pathway of ventral striatum, anterior cingulate cortex. The mesocortical pathway is responsible for the executive function which may change by administration of dopaminergic medication. The mesolimbic pathway is associated with motivation and reward prediction which may result in depression or apathy when dopamine level was suboptimal, impulse control disorder and punding when dopamine was over the optimal level. Abnormal brain metabolism/perfusion related to cognitive impairment in Parkinson's disease are relatively reduced activity located in frontal and parietal association areas and relatively increased activity in the cerebellum. In the anterior brain, the mesocortical pathway, is responsible for verbal memory and executive function, which originates with caudate dopaminergic system and account for mild cognitive impairment of Parkinson's disease. The posterior brain system which includes the parietal, temporal, and occipital cortices, is responsible for the memory and visuospatial function, and related to cholinergic dysfunction and possibly glucocerebrosidase gene variants, relating to dementia in Parkinson's disease. The role of cerebellum in Parkinson's disease remains unclear but emerging evidence suggests that it may relate to the sequencing detection and affective symptoms. The dual syndrome hypothesis is helpful for understanding the mechanism of cognitive impairment in Parkinson's disease and optimal symptom management. 
546 |a EN 
690 |a Parkinson's disease 
690 |a Perfusion 
690 |a Glucose metabolism 
690 |a Dopamine 
690 |a Dual syndrome hypothesis 
690 |a Caudate nucleus 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Biochemistry 
690 |a QD415-436 
655 7 |a article  |2 local 
786 0 |n Molecular Medicine, Vol 27, Iss 1, Pp 1-9 (2021) 
787 0 |n https://doi.org/10.1186/s10020-021-00301-7 
787 0 |n https://doaj.org/toc/1076-1551 
787 0 |n https://doaj.org/toc/1528-3658 
856 4 1 |u https://doaj.org/article/a1c557d4c96e4d5dba1b2811598c3876  |z Connect to this object online.